Sorting out cirrhosis: mechanisms of non‐response to hepatitis C therapy
- 3 June 2015
- journal article
- review article
- Published by Wiley in Liver International
- Vol. 35 (8), 1923-1933
- https://doi.org/10.1111/liv.12861
Abstract
Although cirrhosis has long been recognized as an important negative predictor of treatment response for hepatitis C virus (HCV) therapy, the mechanisms underlying this association remain relatively poorly understood. Treatment has progressed rapidly with the introduction of highly effective all-oral therapies, with promising outcomes even in patients with advanced cirrhosis. However, even with the new therapies, it is clear that patients with cirrhosis require special attention. Efficacy continues to be somewhat reduced compared to non-cirrhotic patients and safety is an important concern. In this review, we explore the reasons for treatment non-response in patients with cirrhosis. We focus on how cirrhosis impacts on four important areas including drug delivery, drug uptake and metabolism, immune responses and drug toxicity with examples from the clinical and basic literature. Fortunately, as treatment continues to progress, many of the challenges of treating patients with cirrhosis will become less and less problematic.This publication has 54 references indexed in Scilit:
- Cirrhosis and Rapid Virological Response to Peginterferon Plus Ribavirin Determine Treatment Outcome in HCV-1 IL28B rs12979860 CC PatientsBioMed Research International, 2013
- MK-5172, a Selective Inhibitor of Hepatitis C Virus NS3/4a Protease with Broad Activity across Genotypes and Resistant VariantsAntimicrobial Agents and Chemotherapy, 2012
- Vitamin D: An innate antiviral agent suppressing hepatitis C virus in human hepatocytesJournal of Hepatology, 2011
- Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patientsJournal of Hepatology, 2011
- Portal Pressure Predicts Outcome and Safety of Antiviral Therapy in Cirrhotic Patients With Hepatitis C Virus InfectionClinical Gastroenterology and Hepatology, 2011
- Malnutrition Impairs Interferon Signaling Through mTOR and FoxO Pathways in Patients With Chronic Hepatitis CGastroenterology, 2011
- Mechanism of Activation of PSI-7851 and Its Diastereoisomer PSI-7977Journal of Biological Chemistry, 2010
- Prevalence of Vitamin D Deficiency in Chronic Liver DiseaseDigestive Diseases and Sciences, 2009
- Bile Acids Promote the Expression of Hepatitis C Virus in Replicon-Harboring CellsJournal of Virology, 2007
- Oxidative stress inhibits IFN-α-induced antiviral gene expression by blocking the JAK–STAT pathwayJournal of Hepatology, 2006